Ceapro Inc. (CVE:CZO – Get Free Report)’s share price was down 11.8% during mid-day trading on Friday . The company traded as low as C$0.23 and last traded at C$0.23. 5,850 shares were traded during trading, a decline of 88% from the average session volume of 50,562 shares. The stock had previously closed at C$0.26.
Ceapro Stock Performance
The company’s 50-day moving average price is C$0.22 and its 200 day moving average price is C$0.23. The company has a debt-to-equity ratio of 8.07, a quick ratio of 18.88 and a current ratio of 8.54. The stock has a market capitalization of C$688,880.00, a PE ratio of -2.83 and a beta of 1.38.
Ceapro Company Profile
Ceapro Inc, a biotechnology company, engages in the development and marketing of health and wellness products and technology relating to plant extracts in the United States, Germany, China, Canada, and internationally. The company is involved in the development of proprietary extraction technologies and the application of these technologies to the production, development, and commercialization of active ingredients, such as oat beta glucan and avenanthramides, which are derived from oats and other renewable plant resources for healthcare and cosmetic industries.
Featured Stories
- Five stocks we like better than Ceapro
- Chevron’s Strong Quarter Shows Why It Still Leads the Energy Sector
- Amazon’s Earnings Beat Shows Why AWS Is Back at the Center of the Bull Case
- Apple’s Record Quarter Could Not Outrun Its Guidance Problem
- McKesson’s Compounding Keeps Adding Up
Receive News & Ratings for Ceapro Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ceapro and related companies with MarketBeat.com's FREE daily email newsletter.
